Related Experiment Video

Updated: Aug 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis

Alessandro M Vannucchi1, Lucia Bianchi, Francesco Paoletti

  • 1Clinical Biochemistry, Istituto Superiore Sanità, Viale Regina Elena 299, 00161 Rome, Italy. migliar@iss.it

Blood
|January 25, 2005
PubMed

Insights

Thrombopoietin (TPO) signaling and GATA-1 regulation are linked in myelofibrosis development. TPO treatment in GATA-1 deficient mice reversed fibrosis, suggesting a shared pathway for this bone marrow disease.

Area of Science:

  • Hematology
  • Molecular Biology
  • Pathology

Background:

  • Idiopathic myelofibrosis (IM) involves bone marrow fibrosis and abnormal megakaryocyte (Mk) differentiation.
  • Existing animal models of myelofibrosis (TPO(high) and GATA-1(low) mice) have distinct genetic alterations but similar disease phenotypes.
  • The pathobiologic link between these models and IM remains unclear.

Purpose of the Study:

  • To investigate the relationship between extrinsic (TPO) and intrinsic (GATA-1) factors in myelofibrosis pathogenesis.
  • To understand the shared mechanisms underlying myelofibrosis in TPO(high) and GATA-1(low) mouse models.

Main Methods:

  • Comparison of TPO levels and Mk morphology in GATA-1(low) and TPO(high) mice.
  • Assessment of transforming growth factor beta1 (TGF-beta1) levels in marrow and spleen.
  • Therapeutic intervention with TPO in GATA-1(low) mice to evaluate effects on GATA-1 content, thrombocytopoiesis, and fibrosis.

Main Results:

  • GATA-1(low) mice had normal plasma TPO levels, but Mks showed abnormalities similar to TPO-treated wild-type mice, with low GATA-1.
  • Myelofibrosis in both models correlated with elevated TGF-beta1.
  • TPO treatment normalized GATA-1 in GATA-1(low) Mks, corrected thrombocytopoiesis, and resolved fibrosis.

Conclusions:

  • The TPO(high) and GATA-1(low) alterations represent an upstream-downstream relationship in a common myelofibrosis pathway.
  • These findings suggest a potential therapeutic target for human idiopathic myelofibrosis.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...